Salt Composition in both
Ciprofloxacin 500mg + Tinidazole 600mg
Salt Composition
(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Ciprofloxacin 500mg Tablet 10s
2,751+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Yes, so IDMAs are getting increasingly profute, and we’ve now created a list of 9 that you can use to access our information.IDMAs, whether in-house or in-the-vicinity, play a crucial role in ensuring that your experience with asthma and related conditions is both informative and engaging. With, you canLODGE™, the natural progression of your asthma management journey, providing you with the opportunity to engage with the experts at IDMAs and experience the nuances within their protocols.
9 brands currently not listed on the site.
Treatment of: bacterial infections of the ear (e.g. otitis media, enuresis).
Respiratory tract infections: respiratory tract infections such as bronchitis, pneumonia, trichomoniasis, adic-neumitis, emphysema, bronchitis, bacterial vaginosis. Tendinitis�
Lower respiratory tract infections: acute, chronic, inflammatory.Tract infections: tonsillitis, pharyngitis, rhinosinusitis, pneurosporitis, zoster pneumonia, prostatitis. Bronchitis: ENTSOBSA (Endpoint-Specific Quality of Life Scale) scores and activity limitation were more than twice as high in patients with bacterial infections of the esophagus, nose, nose, nose, nose, sinus, or vagina, compared to controls.Drug product:Ciprofloxacin (Cipro): Europe licensed for the treatment of acute otitis media (AOM) and bacterial infections of the middle ear (AOMassociated with middle ear infection), sinusitis, bronchitis, cystic fibrosis, tonsillitis, pharyngitis, rhinitis, sinusitis. Trimethoprim is not indicated for the treatment of acute otitis media, acute otitis externa, or treatment of middle ear infection in children (seeLatin and Russian names). Trimethoprim is contraindicated in patients allergic to ciprofloxacin or any other quinolone-related drug.
The daily dose of Cipro is 1 gm. In the European Community the dose is 2 gm, in the European Union the dose is 2 gm in the first and 2 gm in the second day of a 7-day course of therapy.Special recommended not to exceed 50 mg, based on non-standard doses in patients with active infection and response to Cipro treatment
This psychosocial workup was conducted in accordance with the APOM guidelines, as recommended by the European Medicines Agency, and the recommendations and recommendations for use of this workup are consistent with the APOM recommendations. The APOM Working Party (APOM) recommend that treatment with Cipro be restricted to patients with active infection. It is also recommended that treatment with Cipro should be started after the completion of empirical therapy in patients with active infection and the absence of symptoms indicates no infection.
Cipro should not be used in patients with an ear fullness (seeINEapestupuncture). In addition, Cipro is contraindicated in patients with a history of hypersensitivity to ciprofloxacin, to any of the excipients, to the active substance or to any of the excipients' other ingredients.
Treatment:Cipro (ciprofloxacin): General: Cipro should be used with caution in patients with ear fullness (seeINEupuncture).Ciprofloxacin may cause vomiting, diarrhea, nausea, regurgitation, dizziness and/or dizziness in patients with vomiting, nausea, dizziness and/or cramps. Patients with a history of vomiting, diarrhea,// or/ worsening convulsions should be closely monitored. Ciprofloxacin should be used with caution in patients with a history of hypersensitivity to any of the excipients. Cipro has been reported to have a positive effect on bone mineral density in postmenopausal women (seeINEupuncture).
* Based on 50 mg pill split in half
If you’re shopping at CVS or Target, expect to pay about the same as last month:$90.99per 100 milligram pill for brand-name Ciprofloxacin, or$35.09for that same active ingredient. That's twice the dose — $75.01 for a 100 milligram pill and€45.49for a split in half
At Target, both split in half and price compare solid, with Target in the low-lot category and CVS in the “high-dose” category. CVS offers the split in one- and two-month doses, while Target offers both a 100 and two-month supply — a process that Cipro is happy with, but not sure what happened to the $90.99 single-month price at CVS.
The active ingredient in Cipro is quinolone antibiotic ’
Siroil, which is used to treat pulmonary arterial hypertension and pneumonia, is also in the 50 and 100 milligram doses, respectively, of ’s product. That means that if you -- your partner — takes a 100 milligram quinolone antibiotic ’s active ingredient and’divide the dose, you’ll have a 100 milligram dose for each partner’s two.
High-dose “twice” the dose also means that if you take two 50 and 100 milligram pills, you can split them in half and have your partner take the half-dose for a different antibiotic. Target also offers a split in one-month doses, which costs $90.99 for a split in half; $45.49 for a split in half; and€25.49for the split in half, which can be bought with a $30.83 prescription at Target. That’s twice the dose for a 100 milligram pill for each partner.
On average, a 100 milligram quinolone antibiotic ’s active ingredient is35 milligrams” per 100 milligram pill, for a total of over $100, compared to15 milligrams” for a split in half for a 100 milligram dose for each partner.
A year from Target, the split in “
” is already being added to CVS’s 100 milligram quinolone drug program. Cipro, which also owns “” in its name, is still in development, and it’s not know if it’s commercial.We specialize in providing our over 1,000,000 customers with relevant product and condition information created by our professional editorial staff which includes our team of medical writers, medical practitioners, and health educators.
This page is intended to assist consumers in the ways of purchasing medications online, but it is not intended for use by, or supply substitute for, online purchase of any medication or any other product.If you have questions on how to buy a medication online, we encourage a brief online chat with a customer support representative on a game-changing scale to learn more and help you make an informed decision about your medication purchase.
We specialize in providing our over 1,500,000 customers with relevant product and condition information available through ourwen online purchase service. After an online discussion with a customer support professional, the product is sold with with with an knowledgeable and objective customer review, which is carefully weighed before it is made available for purchase. The reviews and opinions expressed herein may not be all that exhaustive or comprehensive, and some potential problems may be experienced by one or more of our regular customers.
The opinions expressed by the reviewers differ from their review posted here as well as from other review boards and purchase bodies. Please discuss your concerns with the review board by visiting the with us to join the other review boards and purchase.com ().
Copyright © 2025 KAMPAGOR CANADA INC. All rights reserved until AUGUST 01, 2025.
The US Food and Drug Administration (FDA) has approved the first drug to prevent a urinary tract infection in children, according to results from a study of children who had taken the antibiotic ciprofloxacin for more than two years.
The drug was approved by the FDA in 2000 and is indicated for the treatment of severe, bacterial infections of the urinary tract, sinus, urinary tract, and other organs.
In the study, the drug was found to be effective at preventing the infection in children who had been taking ciprofloxacin for more than two years. However, the study did not find an effect of the drug on the child’s renal function.
The researchers conducted a follow-up study to see if a drug can prevent an infection in children who took ciprofloxacin. The study found no significant difference in the length of time ciprofloxacin was effective in children who were taking the drug compared to those who were not.
The study was based on a study that compared the treatment of children who took ciprofloxacin for more than two years with that of their children who were not. However, it was concluded that the child’s renal function did not show any significant differences between the two groups. The study also found that the child had a significantly longer time to develop an infection than the children who did not take the drug.
The drug is used to treat a number of infections including infections caused by bacteria that cause ear infections, pneumonia, urinary tract infections, sinusitis, and sexually transmitted infections. Ciprofloxacin is also used to treat other conditions such as urinary tract infections, bronchitis, and infections of the lung and urinary system.
The researchers also noted that the treatment of infections such as urinary tract infections, pneumonia, and other infections may be more effective in children than in those who have had no treatment. They found that ciprofloxacin was effective in children who were receiving antibiotics.
The study concluded that ciprofloxacin can be used to treat the following infections in children who have been taking antibiotics. For example, the FDA recommends that children who have a urinary tract infection be treated with an antibiotic that can prevent the infection.
The researchers also noted that a third of the children had been taking ciprofloxacin for more than two years, and that the treatment was not for a wider range of infections. They also noted that the treatment of other infections has not been adequately studied, and that other treatments are not likely to be effective for these infections.
Overall, they found no significant differences in the length of time the ciprofloxacin was effective in children who were taking the antibiotic compared to those who were not. However, the researchers found that the treatment of the infection in children who had been taking ciprofloxacin had a significantly longer time to develop an infection than those who had not.
The study also found no effect of the drug on renal function.
The study found that the drug was effective in children who had been taking ciprofloxacin for more than two years. However, the research was limited because it was based on a study that did not include children taking antibiotics. As a result, the researchers concluded that ciprofloxacin should not be used in children who have had a urinary tract infection, sinusitis, and other infections.
Ciprofloxacin is an antibiotic that is commonly used to treat many infections including respiratory tract infections, urinary tract infections, sinusitis, and other infections. It is effective in treating infections such as pneumonia and ear and sinus infections, but not for infections caused by bacteria.
The study also found that the antibiotic did not increase the risk of infection in children who were taking the drug.
Researchers found that the drug was effective in children who were taking the antibiotic.
The researchers also noted that ciprofloxacin had been used in children who had been taking antibiotics for more than two years. However, the study was not designed for use in children who had received antibiotics.
The study also found that the drug was effective in children who had been taking the antibiotic for more than two years.
The researchers also found that the drug was effective in children who had been taking the antibiotic for more than two years.
Researchers also noted that the drug was effective in children who had been taking the antibiotic for more than two years.
Researchers found that the drug was effective in children who had been taking the antibiotic for more than two years.
Stade de France Pharmacy